KBC Euro Credit Capital Limited
A Malta-based investment company deploying capital across technology, pharmaceuticals, rare metals and mining — from the heart of the European Union to four continents.
Europe · Middle East · Africa · Americas
Who we are
KBC Euro Credit Capital Limited is a private investment company incorporated in Malta, at the heart of the European Union and the Mediterranean. The company deploys capital across a focused set of high-conviction sectors — information technology and artificial intelligence, pharmaceuticals, rare metals and mining — through equity participations, structured credit and co-investment partnerships.
Our mandate is long-term value creation. We combine the regulatory credibility and treaty network of an EU-domiciled platform with the agility of a privately held investment house, building positions across Europe, the Middle East, Africa and the Americas.
From Malta, the company operates as a single point of structuring, governance and capital allocation for its international portfolio.
- Legal name
- KBC Euro Credit Capital Limited
- Registry number
- C 73896
- Domicile
- Malta — EU Member State
- Register
- Malta Business Registry
- Focus
- Multi-sector international investments
Where we invest
Four sectors chosen for secular growth, strategic relevance and complementary risk: a barbell of long-duration real assets and high-growth intangibles.
IT & Artificial Intelligence
Software platforms, AI infrastructure, applied machine intelligence and digital enterprises across the technology stack.
Pharmaceuticals
Specialty pharma, drug development, manufacturing and life-science services with durable regulatory moats.
Rare Metals
Strategic and critical raw materials — rare earths, lithium, cobalt, PGMs — underpinning the energy transition.
Mining
Exploration, development and producing assets — jurisdiction-first selection, financed via equity, royalties and credit.
Four regions, one platform
Europe
Core market. EU passporting, deep capital markets and industrial-technology champions.
Middle East
Sovereign-linked growth capital, energy transition and infrastructure corridors, with a GCC focus.
Africa
Resource endowment — critical minerals and mining jurisdictions with reform momentum.
Americas
US technology and pharmaceutical depth; resource projects across North and South America.
Holdings & insights
Long-term strategic holdings, sector reports and corporate news. Featured holding:
Bosnalijek d.d. Sarajevo
The largest pharmaceutical manufacturer in Bosnia and Herzegovina — a 75-year-old export-led producer with EU GMP and US FDA accreditation.
#1 shareholder of one of Southeast Europe's most established industrial assets.
Bosnalijek anchors KBC's pharmaceuticals exposure: an export-led manufacturer with EU GMP and US FDA accreditation, a deep product portfolio and a consistent dividend record.
Reports, guides & news
Sector intelligence and corporate updates from KBC Euro Credit Capital.
KBC Euro Credit Capital confirmed as Bosnalijek's largest single shareholder
With a 23.67% stake, KBC sits ahead of AS Holding (19.0%) and the broad institutional and retail free float in one of Southeast Europe's most established industrial assets.
The State of the Rare Metals & Mining Market
Demand for critical minerals is set to grow sharply, with lithium up roughly fivefold by 2040. Supply — and especially processing — is highly concentrated. Africa and the Americas sit at the heart of the diversification story.
Why Malta — Europe's business island
Full EU, eurozone and Schengen membership, an English-speaking common-law-influenced environment, ~5% effective corporate tax via the refund system, and a natural Malta–UAE bridge for groups operating across Europe and the Gulf.